USFDA

USFDA approves novel treatment for Hemophilia; Medication can be given up to once every 2 months – Healthcare News

admin March 30, 2025 0

The U.S. Food and Drug Administration (USFDA) approved Qfitlia (fitusiran) for routine prophylaxis to prevent or reduce the frequency of...

USFDA approves first treatment for patients with liver scarring due to Fatty Liver Disease – Pharma News

admin March 21, 2024 0

The U.S. Food and Drug Administration (USFDA) has approved Rezdiffra (resmetirom) for the treatment of adults with noncirrhotic non-alcoholic steatohepatitis...

USFDA

USFDA approves novel treatment for Hemophilia; Medication can be given up to once every 2 months – Healthcare News

USFDA approves first treatment for patients with liver scarring due to Fatty Liver Disease – Pharma News

Operation Popcorn: B.C. liver recipient thanks health care workers in annual tradition

Patient-led research aims to help others cope with dialysis

UK Trial to Screen 42,000 Patients for Early Liver Disease

$8 Million Raised To Expand Global Chronic Kidney Disease Screening Platform

Optimizing ensemble machine learning models for accurate liver disease prediction in healthcare

USFDA approves novel treatment for Hemophilia; Medication can be given up to once every 2 months – Healthcare News

USFDA approves first treatment for patients with liver scarring due to Fatty Liver Disease – Pharma News

You may have missed

Operation Popcorn: B.C. liver recipient thanks health care workers in annual tradition

Patient-led research aims to help others cope with dialysis

UK Trial to Screen 42,000 Patients for Early Liver Disease

$8 Million Raised To Expand Global Chronic Kidney Disease Screening Platform

Optimizing ensemble machine learning models for accurate liver disease prediction in healthcare